Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ACT.DE Stock Summary
Top 10 Correlated ETFs
ACT.DE
In the News
ACT.DE Financial details
Company Rating
Strong Buy
Market Cap
337.52M
Income
43.23M
Revenue
661.47M
Book val./share
15.95
Cash/share
1.75
Dividend
1.05
Dividend %
4.15%
Employees
1.51K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
8.46
Forward P/E
8.68
PEG
1.91
P/S
0.48
P/B
1.61
P/C
21.03
P/FCF
5.07
Quick Ratio
0.18
Current Ratio
2.22
Debt / Equity
0.37
LT Debt / Equity
0.3
-
-
EPS (TTM)
4.27
EPS next Y
4.24
EPS next Q
-
EPS this Y
14.86%
EPS next Y
-0.76%
EPS next 5Y
15.11%
EPS last 5Y
13.95%
Revenue last 5Y
7.53%
Revenue Q/Q
118.18%
EPS Q/Q
129.41%
-
-
-
-
SMA20
33.46%
SMA50
32.43%
SMA100
55.69%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
20%
ROC
0.15%
Gross Margin
55%
Oper. Margin
9%
Profit Margin
6%
Payout
35%
Shs Outstand
10.14M
Shs Float
4.73M
-
-
-
-
Target Price
-
52W Range
17.55-34.5
52W High
+8.24%
52W Low
+116.47%
RSI
84.49
Rel Volume
2.83
Avg Volume
6.7K
Volume
18.95K
Perf Week
13.23%
Perf Month
57.94%
Perf Quarter
84%
Perf Half Y
84.46%
-
-
-
-
Beta
1.046
-
-
Volatility
1.51%, 3.89%
Prev Close
0.27%
Price
36.8
Change
5.14%
ACT.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 36.96 | 37.27 | 41.62 | 53.5 | 53.16 | |
Net income per share | 1.77 | 1.94 | 2.72 | 2.96 | 3.4 | |
Operating cash flow per share | 4.29 | 4.79 | 4.24 | -0.42 | 7.15 | |
Free cash flow per share | 0.22 | 1.95 | 1.43 | -3.29 | 5.12 | |
Cash per share | 0.91 | 1.72 | 0.86 | 0.95 | 1.75 | |
Book value per share | 5.87 | 6.57 | 8.64 | 14.21 | 15.89 | |
Tangible book value per share | 5.88 | 6.57 | 8.6 | 14.11 | 15.72 | |
Share holders equity per share | 5.87 | 6.57 | 8.64 | 14.21 | 15.89 | |
Interest debt per share | 7.61 | 7.16 | 5.65 | 10.19 | 6.07 | |
Market cap | 213.7M | 213.7M | 234.39M | 170.28M | 269.49M | |
Enterprise value | 276.74M | 265.65M | 281.75M | 261.27M | 320.1M | |
P/E ratio | 11.89 | 10.85 | 8.49 | 5.67 | 7.78 | |
Price to sales ratio | 0.57 | 0.56 | 0.56 | 0.31 | 0.5 | |
POCF ratio | 4.9 | 4.39 | 5.45 | -40.16 | 3.71 | |
PFCF ratio | 95.02 | 10.75 | 16.19 | -5.11 | 5.17 | |
P/B Ratio | 3.58 | 3.19 | 2.67 | 1.18 | 1.67 | |
PTB ratio | 3.58 | 3.19 | 2.67 | 1.18 | 1.67 | |
EV to sales | 0.74 | 0.7 | 0.67 | 0.48 | 0.59 | |
Enterprise value over EBITDA | 5.5 | 4.91 | 4.49 | 4.04 | 4.1 | |
EV to operating cash flow | 6.34 | 5.45 | 6.55 | -61.62 | 4.4 | |
EV to free cash flow | 123.05 | 13.36 | 19.46 | -7.84 | 6.14 | |
Earnings yield | 0.08 | 0.09 | 0.12 | 0.18 | 0.13 | |
Free cash flow yield | 0.01 | 0.09 | 0.06 | -0.2 | 0.19 | |
Debt to equity | 1.21 | 1.03 | 0.63 | 0.7 | 0.37 | |
Debt to assets | 0.21 | 0.19 | 0.15 | 0.24 | 0.14 | |
Net debt to EBITDA | 1.25 | 0.96 | 0.76 | 1.41 | 0.65 | |
Current ratio | 2.16 | 2.21 | 2 | 1.62 | 2.62 | |
Interest coverage | 5.76 | 8.14 | 22.44 | 12.89 | 19.99 | |
Income quality | 1.71 | 1.79 | 1.18 | -0.1 | 2.1 | |
Dividend Yield | 0.04 | 0.04 | 0.03 | 0.06 | 0.04 | |
Payout ratio | 0.51 | 0.39 | 0.28 | 0.34 | 0.31 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.95 | -0.59 | -0.66 | 6.86 | -0.28 | |
Capex to revenue | -0.11 | -0.08 | -0.07 | -0.05 | -0.04 | |
Capex to depreciation | -2.12 | -1.25 | -1.17 | -1.14 | -0.79 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.28 | 16.92 | 22.99 | 30.79 | 34.89 | |
ROIC | 0.16 | 0.16 | 0.19 | 0.11 | 0.17 | |
Return on tangible assets | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | |
Graham Net | -20.18 | -20.2 | -19.65 | -15.34 | -12.42 | |
Working capital | 70.12M | 72.58M | 76.46M | 82.53M | 133.95M | |
Tangible asset value | 59.81M | 66.85M | 87.24M | 142.99M | 159.9M | |
Net current asset value | -150.63M | -153.18M | -135.52M | -62.28M | -44.54M | |
Invested capital | 1.21 | 1.03 | 0.63 | 0.7 | 0.37 | |
Average receivables | 19.7M | 39.12M | 44.14M | 58.46M | 75.91M | |
Average payables | 27.47M | 22.47M | 26.83M | 35.08M | 34.47M | |
Average inventory | 76.53M | 70.57M | 76.37M | 104.06M | 114.9M | |
Days sales outstanding | 38.23 | 37.38 | 42.72 | 45.43 | 56.93 | |
Days payables outstanding | 63.3 | 59.23 | 77.72 | 52.59 | 28.5 | |
Days of inventory on hand | 195.15 | 189.84 | 203.44 | 172.05 | 97.08 | |
Receivables turnover | 9.55 | 9.76 | 8.54 | 8.03 | 6.41 | |
Payables turnover | 5.77 | 6.16 | 4.7 | 6.94 | 12.81 | |
Inventory turnover | 1.87 | 1.92 | 1.79 | 2.12 | 3.76 | |
ROE | 0.3 | 0.29 | 0.31 | 0.21 | 0.21 | |
Capex per share | -4.07 | -2.83 | -2.81 | -2.87 | -2.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.24 | 14.82 | 12.46 | 11.92 | 26.01 | |
Net income per share | 0.68 | 0.76 | 0.71 | 0.85 | 1.95 | |
Operating cash flow per share | 0.98 | 1.01 | 2.91 | 0.48 | 3.24 | |
Free cash flow per share | -0.41 | 0.54 | 2.54 | 0.48 | 2.06 | |
Cash per share | 0.96 | 1.24 | 1.22 | 1.82 | 1.75 | |
Book value per share | 14.32 | 14.71 | 14.4 | 15.73 | 15.95 | |
Tangible book value per share | 14.22 | 14.6 | 13.76 | 15.11 | 15.78 | |
Share holders equity per share | 14.32 | 14.71 | 14.4 | 15.73 | 15.95 | |
Interest debt per share | 10.07 | 0.19 | 8.08 | 0.16 | 6.08 | |
Market cap | 168.97M | 197.4M | 198.68M | 202.66M | 268.6M | |
Enterprise value | 259.96M | 189.28M | 269.85M | 185.93M | 319.2M | |
P/E ratio | 6.18 | 6.44 | 6.9 | 5.88 | 3.4 | |
Price to sales ratio | 1.27 | 1.31 | 1.57 | 1.68 | 1.02 | |
POCF ratio | 17.14 | 19.27 | 6.72 | 41.44 | 8.17 | |
PFCF ratio | -40.94 | 36.31 | 7.7 | 41.44 | 12.87 | |
P/B Ratio | 1.17 | 1.32 | 1.36 | 1.27 | 1.66 | |
PTB ratio | 1.17 | 1.32 | 1.36 | 1.27 | 1.66 | |
EV to sales | 1.95 | 1.26 | 2.13 | 1.54 | 1.21 | |
Enterprise value over EBITDA | 15.48 | 9.98 | 15.01 | 9.21 | 7.57 | |
EV to operating cash flow | 26.37 | 18.48 | 9.13 | 38.02 | 9.71 | |
EV to free cash flow | -62.99 | 34.82 | 10.46 | 38.02 | 15.29 | |
Earnings yield | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | |
Free cash flow yield | -0.02 | 0.03 | 0.13 | 0.02 | 0.08 | |
Debt to equity | 0.7 | 0 | 0.55 | 0 | 0.37 | |
Debt to assets | 0.24 | 0 | 0.19 | 0 | 0.14 | |
Net debt to EBITDA | 5.42 | -0.43 | 3.96 | -0.83 | 1.2 | |
Current ratio | 1.62 | 2.12 | 2.21 | 2.22 | 2.62 | |
Interest coverage | 9.85 | 6.72 | 7.01 | 8.59 | 11.7 | |
Income quality | 1.44 | 1.34 | 2.96 | 0 | 1.66 | |
Dividend Yield | 0 | 0 | 0.05 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.48 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.02 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0 | 0.03 | 0 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | |
Capex to operating cash flow | -1.42 | -0.47 | -0.13 | 0 | -0.36 | |
Capex to revenue | -0.11 | -0.03 | -0.03 | 0 | -0.05 | |
Capex to depreciation | -2.11 | -0.76 | -0.59 | 0 | -0.9 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 14.79 | 15.81 | 15.15 | 17.35 | 26.44 | |
ROIC | 0.03 | 0.06 | 0.04 | 0.06 | 0.09 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | |
Graham Net | -15.46 | -20.85 | -14.99 | -18.41 | -12.47 | |
Working capital | 82.53M | 120.95M | 118.02M | 125.28M | 133.95M | |
Tangible asset value | 142.99M | 148.23M | 139.82M | 153.07M | 159.9M | |
Net current asset value | -62.28M | -55.49M | -55.1M | -40.13M | -44.54M | |
Invested capital | 0.7 | 0 | 0.55 | 0 | 0.37 | |
Average receivables | 33.74M | 33.74M | 28.6M | 28.6M | 42.16M | |
Average payables | 18.69M | 18.69M | 19.35M | 19.35M | 15.78M | |
Average inventory | 126.9M | 121.14M | 123.23M | 125.88M | 116.37M | |
Days sales outstanding | 45.6 | 0 | 40.67 | 0 | 28.79 | |
Days payables outstanding | 53.17 | 0 | 66.58 | 0 | 14.94 | |
Days of inventory on hand | 173.97 | 143.49 | 217.57 | 232.95 | 50.88 | |
Receivables turnover | 1.97 | 0 | 2.21 | 0 | 3.13 | |
Payables turnover | 1.69 | 0 | 1.35 | 0 | 6.02 | |
Inventory turnover | 0.52 | 0.63 | 0.41 | 0.39 | 1.77 | |
ROE | 0.05 | 0.05 | 0.05 | 0.05 | 0.12 | |
Capex per share | -1.39 | -0.47 | -0.37 | 0 | -1.18 |
ACT.DE Frequently Asked Questions
What is AlzChem Group AG stock symbol ?
AlzChem Group AG is a DE stock and trading under the symbol ACT.DE
What is AlzChem Group AG stock quote today ?
AlzChem Group AG stock price is $36.8 today.
Is AlzChem Group AG stock public?
Yes, AlzChem Group AG is a publicly traded company.